Newly Emerged Superbug Discovered
By LabMedica International staff writers Posted on 15 Sep 2017 |
Image: The VITEK 2 COMPACT instrument offers the capacity to help improve therapeutic success and patient outcomes through reliable microbial identification (ID) and antibiotic susceptibility testing (AST) (Photo courtesy of bioMérieux).
Hypervirulent Klebsiella pneumoniae strains often cause life-threatening community-acquired infections in young and healthy hosts, but are usually sensitive to antibiotics.
A newly emerged superbug, hyper-resistant and hypervirulent K. pneumoniae, has been discovered, which may cause untreatable and fatal infections in relatively healthy individuals and will pose enormous threat to human health.
Scientists at The Hong Kong Polytechnic University (Kowloon, Hong Kong Special Administrative Region, China) and their colleagues conducted an investigation into a fatal outbreak of pneumonia in the Second Affiliated Hospital of Zhejiang University (Hangzhou, China) in February 2016. The study involved five patients who underwent surgical operation for multiple-trauma. All of them were later infected in the intensive care unit (ICU) and developed severe pneumonia, and eventually died of septicemia and multiple organ failure. The patients were aged 53 to 73 years and were admitted to the intensive care unit between late February and April 2016.
The team collected 21 carbapenem-resistant K. pneumoniae strains from five patients and characterized these strains for their antimicrobial susceptibility, multilocus sequence types, and genetic relatedness using the VITEK-2 compact system (bioMérieux, Marcy-l'Étoile, France), multilocus sequence typing, and whole genome sequencing. The causative agent of these five patients was found to be a carbapenem-resistant K. pneumoniae (CRKP) strain, a type of previously defined superbug. Furthermore, these CRKP strains are also hypervirulent and belong to ST11 type of CRKP, the most prevalent and transmissible CRKP strains in Asia. Genomic analyses showed that the emergence of these ST11 carbapenem-resistant hypervirulent K pneumoniae strains was due to the acquisition of a roughly 170 kbp pLVPK-like virulence plasmid by classic ST11 carbapenem-resistant K. pneumoniae strains. They also detected these strains in specimens collected in other regions of China.
The ST11 CR-HvKP strains do not only infect lungs and cause pneumonia, but also invade the bloodstream and other internal organs. Due to its hypervirulence and phenotypic resistance to commonly used antibiotics, ST11 CR-HvKP strains may cause untreatable and fatal infections in relatively healthy individuals with normal immunity. The study was published on August 29, 2017, in the journal The Lancet Infectious Diseases.
A newly emerged superbug, hyper-resistant and hypervirulent K. pneumoniae, has been discovered, which may cause untreatable and fatal infections in relatively healthy individuals and will pose enormous threat to human health.
Scientists at The Hong Kong Polytechnic University (Kowloon, Hong Kong Special Administrative Region, China) and their colleagues conducted an investigation into a fatal outbreak of pneumonia in the Second Affiliated Hospital of Zhejiang University (Hangzhou, China) in February 2016. The study involved five patients who underwent surgical operation for multiple-trauma. All of them were later infected in the intensive care unit (ICU) and developed severe pneumonia, and eventually died of septicemia and multiple organ failure. The patients were aged 53 to 73 years and were admitted to the intensive care unit between late February and April 2016.
The team collected 21 carbapenem-resistant K. pneumoniae strains from five patients and characterized these strains for their antimicrobial susceptibility, multilocus sequence types, and genetic relatedness using the VITEK-2 compact system (bioMérieux, Marcy-l'Étoile, France), multilocus sequence typing, and whole genome sequencing. The causative agent of these five patients was found to be a carbapenem-resistant K. pneumoniae (CRKP) strain, a type of previously defined superbug. Furthermore, these CRKP strains are also hypervirulent and belong to ST11 type of CRKP, the most prevalent and transmissible CRKP strains in Asia. Genomic analyses showed that the emergence of these ST11 carbapenem-resistant hypervirulent K pneumoniae strains was due to the acquisition of a roughly 170 kbp pLVPK-like virulence plasmid by classic ST11 carbapenem-resistant K. pneumoniae strains. They also detected these strains in specimens collected in other regions of China.
The ST11 CR-HvKP strains do not only infect lungs and cause pneumonia, but also invade the bloodstream and other internal organs. Due to its hypervirulence and phenotypic resistance to commonly used antibiotics, ST11 CR-HvKP strains may cause untreatable and fatal infections in relatively healthy individuals with normal immunity. The study was published on August 29, 2017, in the journal The Lancet Infectious Diseases.
Latest Microbiology News
- High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes
- Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment
- Non-Invasive Stool Test to Diagnose Endometriosis and Help Reduce Disease Progression
- Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR
- Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics
- New Digital PCR Assays Enable Accurate and Sensitive Detection of Critical Pathogens
- Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results
- AST System Delivers Actionable Results for Gram-Negative Bacteria Directly from Positive Blood Cultures
- Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours
- New Rapid Method for Determining Virus Infectivity Could Revolutionize Response to Future Pandemics
- Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings
- Innovative C. Difficile Diagnostic Test Provides Both GDH and Toxin Results within 30 Minutes
- Rapid UTI Test Cuts Detection Time from 3 days to 45 Minutes
- POC STI Test Shortens Time from ED Arrival to Test Results
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections